Chain Antimicrobials Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

Chain Antimicrobials General Information

Description

Developer of antimicrobial-coated medical devices designed to prevent the formation of healthcare-associated infections. The company's devices are coated with peptides derived from crowberry which develops resistance in bacteria and fungal species such as E. coli and Candida spp, enabling doctors and healthcare providers to reduce the risk of infection and prevent deaths.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Teknologiantie 2
  • 90590 Oulu
  • Finland
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Teknologiantie 2
  • 90590 Oulu
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chain Antimicrobials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 01-Feb-2022 Completed Bankruptcy: Liquidation
3. Accelerator/Incubator 10-Jan-2020 Completed Pre-Clinical Trials
2. Early Stage VC 25-Sep-2018 $817K $975K Completed Pre-Clinical Trials
1. Early Stage VC 28-Nov-2017 $159K $159K Completed Startup
To view Chain Antimicrobials’s complete valuation and funding history, request access »

Chain Antimicrobials Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Chain Antimicrobials’s complete cap table history, request access »

Chain Antimicrobials Patents

Chain Antimicrobials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10457709-B2 Antimicrobial peptides, their variants and uses Active 30-Jun-2015
US-10457710-B2 Antimicrobial peptides, their variants and uses Active 30-Jun-2015
US-10555988-B2 Antimicrobial peptides, their variants and uses Active 30-Jun-2015
US-11096985-B2 Antimicrobial peptides, their variants and uses Active 30-Jun-2015
US-20200138901-A1 Antimicrobial peptides, their variants and uses Active 30-Jun-2015 A61K38/168
To view Chain Antimicrobials’s complete patent history, request access »

Chain Antimicrobials Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chain Antimicrobials FAQs

  • When was Chain Antimicrobials founded?

    Chain Antimicrobials was founded in 2017.

  • Where is Chain Antimicrobials headquartered?

    Chain Antimicrobials is headquartered in Oulu, Finland.

  • What is the size of Chain Antimicrobials?

    Chain Antimicrobials has 3 total employees.

  • What industry is Chain Antimicrobials in?

    Chain Antimicrobials’s primary industry is Therapeutic Devices.

  • Is Chain Antimicrobials a private or public company?

    Chain Antimicrobials is a Private company.

  • What is Chain Antimicrobials’s current revenue?

    The current revenue for Chain Antimicrobials is .

  • How much funding has Chain Antimicrobials raised over time?

    Chain Antimicrobials has raised $975K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process